Anika Therapeutics (ANIK) Expected to Announce Earnings on Wednesday

Anika Therapeutics (NASDAQ:ANIK) is projected to release its earnings data after the market closes on Wednesday, March 12th. Analysts expect Anika Therapeutics to post earnings of ($0.01) per share and revenue of $29.00 million for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Anika Therapeutics Trading Down 0.7 %

Shares of NASDAQ ANIK opened at $16.50 on Tuesday. The firm has a 50-day moving average of $16.91 and a two-hundred day moving average of $19.73. The company has a market capitalization of $241.66 million, a price-to-earnings ratio of -2.48 and a beta of 0.95. Anika Therapeutics has a twelve month low of $15.40 and a twelve month high of $29.11.

Anika Therapeutics Company Profile

Anika Therapeutics, Inc, a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.